BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23515849)

  • 1. Actions of Agonists and Antagonists of the ghrelin/GHS-R Pathway on GH Secretion, Appetite, and cFos Activity.
    Hassouna R; Labarthe A; Zizzari P; Videau C; Culler M; Epelbaum J; Tolle V
    Front Endocrinol (Lausanne); 2013; 4():25. PubMed ID: 23515849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain.
    Halem HA; Taylor JE; Dong JZ; Shen Y; Datta R; Abizaid A; Diano S; Horvath TL; Culler MD
    Neuroendocrinology; 2005; 81(5):339-49. PubMed ID: 16210868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A natural variant of obestatin, Q90L, inhibits ghrelin's action on food intake and GH secretion and targets NPY and GHRH neurons in mice.
    Hassouna R; Zizzari P; Viltart O; Yang SK; Gardette R; Videau C; Badoer E; Epelbaum J; Tolle V
    PLoS One; 2012; 7(12):e51135. PubMed ID: 23251435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
    Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
    Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel analogs of ghrelin: physiological and clinical implications.
    Halem HA; Taylor JE; Dong JZ; Shen Y; Datta R; Abizaid A; Diano S; Horvath T; Zizzari P; Bluet-Pajot MT; Epelbaum J; Culler MD
    Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S71-5. PubMed ID: 15339248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor.
    Zizzari P; Halem H; Taylor J; Dong JZ; Datta R; Culler MD; Epelbaum J; Bluet-Pajot MT
    Endocrinology; 2005 Sep; 146(9):3836-42. PubMed ID: 15919752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss.
    Esler WP; Rudolph J; Claus TH; Tang W; Barucci N; Brown SE; Bullock W; Daly M; Decarr L; Li Y; Milardo L; Molstad D; Zhu J; Gardell SJ; Livingston JN; Sweet LJ
    Endocrinology; 2007 Nov; 148(11):5175-85. PubMed ID: 17656463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Growth Hormone Secretagogue Receptor Deletion on Growth, Pulsatile Growth Hormone Secretion, and Meal Pattern in Male and Female Mice.
    Labarthe A; Zizzari P; Fiquet O; Lebrun N; Veldhuis JD; Roelfsema F; Chauveau C; Bohlooly-Y M; Epelbaum J; Tolle V
    Neuroendocrinology; 2022; 112(3):215-234. PubMed ID: 33774644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity.
    Lu X; Huang L; Huang Z; Feng D; Clark RJ; Chen C
    Front Endocrinol (Lausanne); 2021; 12():717544. PubMed ID: 34512549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor.
    Toshinai K; Yamaguchi H; Sun Y; Smith RG; Yamanaka A; Sakurai T; Date Y; Mondal MS; Shimbara T; Kawagoe T; Murakami N; Miyazato M; Kangawa K; Nakazato M
    Endocrinology; 2006 May; 147(5):2306-14. PubMed ID: 16484324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats.
    Tamura H; Kamegai J; Shimizu T; Ishii S; Sugihara H; Oikawa S
    Endocrinology; 2002 Sep; 143(9):3268-75. PubMed ID: 12193538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor.
    Ghigo E; Broglio F; Arvat E; Maccario M; Papotti M; Muccioli G
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):1-17. PubMed ID: 15638864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth hormone secretagogue receptor (Ghs-R).
    Laviano A; Molfino A; Rianda S; Rossi Fanelli F
    Curr Pharm Des; 2012; 18(31):4749-54. PubMed ID: 22632856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
    Yakabi K; Kurosawa S; Tamai M; Yuzurihara M; Nahata M; Ohno S; Ro S; Kato S; Aoyama T; Sakurada T; Takabayashi H; Hattori T
    Regul Pept; 2010 Apr; 161(1-3):97-105. PubMed ID: 20171995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers.
    Lawrence CB; Snape AC; Baudoin FM; Luckman SM
    Endocrinology; 2002 Jan; 143(1):155-62. PubMed ID: 11751604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells.
    Rubinfeld H; Hadani M; Taylor JE; Dong JZ; Comstock J; Shen Y; DeOliveira D; Datta R; Culler MD; Shimon I
    Eur J Endocrinol; 2004 Dec; 151(6):787-95. PubMed ID: 15588247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
    Muccioli G; Baragli A; Granata R; Papotti M; Ghigo E
    Neuroendocrinology; 2007; 86(3):147-64. PubMed ID: 17622734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin: endocrine, metabolic and cardiovascular actions.
    Broglio F; Prodam F; Me E; Riganti F; Lucatello B; Granata R; Benso A; Muccioli G; Ghigo E
    J Endocrinol Invest; 2005; 28(5 Suppl):23-5. PubMed ID: 16114271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs.
    Rhodes L; Zollers B; Wofford JA; Heinen E
    Vet Med Sci; 2018 Feb; 4(1):3-16. PubMed ID: 29468076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.
    Mosa R; Huang L; Li H; Grist M; LeRoith D; Chen C
    Am J Physiol Regul Integr Comp Physiol; 2018 Jan; 314(1):R71-R83. PubMed ID: 28903914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.